BOSTON, MA, USA I1, 2025 I Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from ...

PhD Defense of W.P.J. Cox (UMC Utrecht/Kinderen) ...

Adc Therapeutics SA (ADCT), a biotechnology firm specializing in the development of antibody-drug conjugates for cancer treatment, has seen its stock price touch a 52-week low, reaching $1.66. With a ...

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).

Dara Khosrowshahi, CEO of Uber, championed the role of AI in transforming the physical world at the conference. He proclaimed that the future of transportation is "electric, autonomous, and shared." ...

The Schwab U.S. Dividend Equity ETF offers automatic diversification, income, and growth. Read what makes SCHD a solid ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine ...

2025 is set to be a game-changing year for cancer research, with cutting-edge therapies and technologies driving unprecedented progress in oncology.

ArriVent BioPharma inks exclusive license with Lepu Biopharma for MRG007, an ADC to treat gastrointestinal cancers: Newtown Square, Pennsylvania Thursday, January 23, 2025, 12:00 ...

Zai Lab Limited (ZLAB) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation or ODD to ZL-1310, a ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.